Ariz. Admin. Code § 4-19-512

Current through Register Vol. 30, No. 45, November 8, 2024

Section R4-19-512 - Prescribing Drugs and Devices

A. An RNP, CNM, or CNS granted P & D authority by the Board may, within restrictions provided by law and applicable to each certificate:

1. Prescribe drugs and devices;

2. Provide for refill of prescription-only drugs and devices for one year from the date of the prescription.

B. An RNP, CNM, or CNS with P & D authority who wishes to prescribe a controlled substance shall obtain a DEA registration number before prescribing a controlled substance, and shall file the DEA registration number with the Board.

C. An RNP, CNM, or CNS with a DEA registration number may prescribe, but may not exceed the limitations of each certification:

1. A Schedule II controlled substance as defined in the federal Controlled Substances Act, 21 U.S.C. § 801 et seq., or Arizona's Uniform Controlled Substances Act, A.R.S. Title 36, Chapter 27, but shall not prescribe refills of the prescription, and shall follow all other restrictions provided by law;

2. A Schedule III or IV controlled substance, as defined in the federal Controlled Substances Act or Arizona's Uniform Controlled Substances Act, and may prescribe a maximum of five refills in six months; and

3. A Schedule V controlled substance, as defined in the federal Controlled Substances Act or Arizona's Uniform Controlled Substances Act, and may prescribe refills for a maximum of one year.

D. An RNP, CNM, or CNS whose DEA registration is revoked or expires shall not prescribe controlled substances. An RNP, CNM, or CNS whose DEA registration is revoked or limited shall report the action to the Board within 10 days of the revocation or limitation.

E. In all outpatient settings or at the time of hospital discharge, an RNP, CNM, or CNS with P & D authority, who prescribed medication to a patient, shall personally provide the patient or the patient's representative with the name of the drug, directions for use, and any special instructions, precautions, or storage requirements necessary for safe and effective use of the drug if any of the following occurs:

1. A new drug is prescribed or there is a change in the dose, form, or direction for use in a previously prescribed drug;

2. In the RNP's, CNM's, or CNS's professional judgment, these instructions are warranted; or

3. The patient or patient's representative requests instruction.

F. An RNP, CNM, or CNS with P & D authority shall ensure that all prescription orders contain the following:

1. The RNP's, CNM's, or CNS's name, address, telephone number, and population focus;

2. The prescription date;

3. The name of the patient and either the address of the patient or a blank for the address if the prescription is not being dispensed by the RNP, CNM, or CNS;

4. The full name of the drug, strength, dosage form, and directions for use;

5. The letters "DAW", "dispense as written", "do not substitute", "medically necessary" or any similar statement on the face of the prescription form if intending to prevent substitution of the drug;

6. The RNP's, CNM's, or CNS's DEA registration number, if applicable; and

7. The RNP's, CNM's, or CNS's signature.

Ariz. Admin. Code § R4-19-512

Former R4-19-512 renumbered to R4-19-514; new R4-19-512made by final rulemaking at 11 A.A.R. 3804, effective November 12, 2005 (05-3). Amended by final rulemaking at 19 A.A.R. 1438, effective July 6, 2013 (Supp. 13-2). Amended by final rulemaking at 26 A.A.R. 3289, effective 12/2/2020.